Medicine details
Image | |
Name | Mefoglip 2.5/250 |
Dosage | Tablet |
Generic Name | Glipizide + Metformin Hydrochloride |
Classes |
Antidiabetic Agent Metabolic Agent Antidiabetic combination |
Diseases |
Type 2 Diabetes Mellitus Hormonal Disorder |
Company | Incepta Pharmaceuticals Ltd. |
Drug Package Details
Strength | 2.5 mg + 250 mg |
Storage Condition | |
Origin Country | Bangladesh |
Commercial Pack | 50 |
Price per pack | ৳ 95.00 |
Cost per pack | ৳ 83.60 |
Package unit | 10 tabs strip |
Price per unit | ৳ 1.90 |
Cost per unit | ৳ 1.67 |
Discount | 0 |
Coupon | |
Remarks |
Glipizide + Metformin Hydrochloride
Glipizide + Metformin Hydrochloride is an antidiabetic combination of Glipizide & Metformin. Glipizide belongs to the sulfonylurea class of antidiabetic drugs. Glipizide is an insulin secretagogue which works by inhibiting K+ channels of beta cells and ultimately increasing the secretion of insulin. Metformin is a hypoglycemic agent belonging to the class Biguanides. Metformin enhances insulin sensitivity by boosting peripheral glucose uptake and utilization, decreasing hepatic glucose synthesis, and decreasing intestinal glucose absorption.
Glipizide + Metformin Hydrochloride is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Dosage of METAGLIP must be individualized on the basis of both effectiveness and tolerance while not exceeding the maximum recommended daily dose of 20 mg glipizide/2000 mg metformin.